ADORA3 and psoriasis: Targeting the receptor with the highly specific agonist piclidenoson, A3AR induced the inhibition of HaCat cell proliferation, a spontaneously immortalized human epithelial line that maintains full epidermal differentiation capacity and has been widely used as an in vitro model for the study of psoriasis [22, 23].